BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Oct 26, 2022 1:17pm

56 Views

Post# 35050483

BIOV 600K COULD BE ANOTHER MILLION TRADE DAY

C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com

13:16:23 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BIOV - C	8.5	0.20	·	0.21	3.5	0.20	-0.025	-11.1	582.4	118	108	0.23 0.23 0.195	0.395 0.085	12:57:01	Oct 14	15 min RT 2¢
CSE - C	8.5	0.20	·	0.21	3.5	0.21	-0.015	-6.7	302.3	61	70	0.23 0.23 0.195	0.395 0.085	12:45:42		15 min
NEO ATS - U						0.20	-0.025	-11.1	244.5	50	31	0.22 0.22 0.20		12:57:01		15 min
Omega - O						0.21	-0.015	-6.7	29.5	6	4	0.22 0.22 0.205		12:45:42		15 min
CX2 - H						0.21	-0.015	-6.7	6.0	1	2	0.21 0.21 0.21		12:31:47		15 min
TriAct - M						0.225			0.1		1					15 min